All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Exempt, with results | 2007-004819-54 | A phase I/II, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous doses of PRO051 in patients with Duchenne muscular dystr... | 2016-09-09 | not-yet-due |
| Exempt, with results | 2009-013762-63 | A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous and intravenous doses of PRO044 in patients with Duchen... | 2013-07-30 | not-yet-due |
| Exempt, with results | 2011-005040-10 | A phase I/II, open-label study to assess the efficacy, safety, pharmacodynamics and pharmacokinetics of multiple doses of PRO045 in subjects with Duchenne muscular dystrophy STUDIO IN APERTO DI FAS... | 2016-09-09 | not-yet-due |
| Listed as ongoing, but also has a completion date and reported results | 2011-005042-35 | A Phase I/II, open-label, dose escalating with 48 week treatment study to assess the safety and tolerability, pharmacokinetics, pharmacodynamics and efficacy of BMN 053 (previously known as PRO053) in... | 2016-09-09 | bad-data |
| Reported results | 2013-003605-26 | A phase II, open label, extension study to assess the effect of PRO044 in patients with Duchenne muscular dystrophy | 2016-08-05 | due-trials |